# CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27.

> **NIH NIH N01** · THE EMMES COMPANY, LLC · 2024 · $256,829

## Abstract

This contract supports work that is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative bolsters research across NIH to improve treatment for opioid misuse and addiction and to develop concrete strategies capable of providing rapid and durable solutions to the opioid crisis.

## Key facts

- **NIH application ID:** 11219441
- **Project number:** 75N95020D00012-P00001-759502300004-2
- **Recipient organization:** THE EMMES COMPANY, LLC
- **Principal Investigator:** EVE JELSTROM
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $256,829
- **Award type:** —
- **Project period:** 2023-08-28 → 2025-08-27

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11219441

## Citation

> US National Institutes of Health, RePORTER application 11219441, CCC TO 11 - CTN-0145: STANDARD VERSUS HIGH DOSE ED-INITIATED BUPRENORPHINE INDUCTION. POP: 8/28/23 - 8/27/27. (75N95020D00012-P00001-759502300004-2). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11219441. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*